LK Law Firm’s Lena Kempe explores the growing impact of artificial intelligence and how government regulation is pushing ...

The FDA is releasing the first-ever guidance on how the pharmaceutical industry can use AI. Nick Kostos and Femi Abebefe ...

AI can compare thousands of images to uncover dangerous patterns, create ultra-high resolution scans from low-res images and ...

House Looks To Rep. Obernolte to Take Lead on AI Representative Jay Obernolte (R-Calif.) has emerged as a pivotal figure in ...

Of the 1,757 total AI use cases reported by federal agencies last year, 227 of them were listed as safety- or ...

What will shape AI governance? Industry leaders share key insights, highlighting diverse yet interconnected factors driving ...

The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...

In this edition of InnovationRx, medical debts will be erased from credit histories, this farm is doubling down on raw milk ...

Shares of Sana Biotechnology Inc. (NASDAQ: SANA) were trading at $4.97, up $3.32, or 201%, on first results from an investigator-sponsored, first-in-human study transplanting UP-421, an allogeneic ...

The FDA has shared draft guidance on the design and development of AI-enabled medical devices and marketing submissions for those devices.

The FDA has released draft guidance for developers of AI-enabled medical devices, offering recommendations aimed at ensuring the safety and effectiveness of the devices.